Indication: Staphylococcus

A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight (VLBW) Neonates for the Prevention of Staphylococcal Sepsis

Sub-indication: Staphylococcus

Drug Study

Principal Investigator: Dan Stewart, M.D.
Norton Children's Neonatology, affiliated with the UofL School of Medicine

Sponsor: Biosynexus Incorporated

Search our entire site.